PRESS RELEASE published on 07/15/2024 at 08:00, 2 years ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 96,832 of its ordinary shares on Euronext Dublin and London Stock Exchange, part of the share buyback program announced on 3 July 2024 London Stock Exchange Share Buyback Program Cairn Homes Plc Euronext Dublin Goodbody Stockbrokers UC
BRIEF published on 07/12/2024 at 08:05, 2 years ago Cairn Homes Plc: Share Repurchase Update London Stock Exchange Share Repurchase Euronext Dublin Cairn Homes Buyback Programme
BRIEF published on 07/12/2024 at 08:05, 2 years ago Cairn Homes Plc : mise à jour sur le rachat d'actions Rachat D'actions Euronext Dublin Programme De Rachat Bourse De Londres Maisons Cairn
PRESS RELEASE published on 07/12/2024 at 08:00, 2 years ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 100,000 of its own shares on Euronext Dublin and London Stock Exchange, cancelling them as part of the share buyback program London Stock Exchange Share Buyback Program Cairn Homes Plc Euronext Dublin Cancellation
BRIEF published on 07/11/2024 at 08:05, 2 years ago Cairn Homes Plc Buys Back Shares on Euronext Dublin and London Stock Exchange London Stock Exchange Share Buyback Financial News Euronext Dublin Cairn Homes
BRIEF published on 07/11/2024 at 08:05, 2 years ago Cairn Homes Plc rachète des actions sur Euronext Dublin et la Bourse de Londres Rachat D'actions Euronext Dublin Bourse De Londres Actualités Financières Maisons Cairn
PRESS RELEASE published on 07/11/2024 at 08:00, 2 years ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase of 203,433 of its ordinary shares for cancellation. The buyback program aims to enhance shareholder value Share Buyback Cairn Homes Plc Stock Exchange Cancellation Transaction
BRIEF published on 07/10/2024 at 08:05, 2 years 1 month ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Stock Transaction
BRIEF published on 07/10/2024 at 08:05, 2 years 1 month ago Cairn Homes Plc : Transaction sur actions propres Rachat D'actions Euronext Dublin Transaction Boursière Bourse De Londres Maisons Cairn
PRESS RELEASE published on 07/10/2024 at 08:00, 2 years 1 month ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 210,000 ordinary shares on Euronext Dublin and the London Stock Exchange. The repurchased shares will be cancelled Share Buyback Programme Cairn Homes Plc Euronext Dublin Own Shares Transaction
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 19 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 46 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 46 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
